Pravin Dugel insider trades: Ocular Therapeutix (OCUL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pravin reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | OCUL | ↓ Sell | 21,649 | $10.77 | $233K | Direct | Aug 26, 2026 (2d) |
| May 26, 2026 | OCUL | ↓ Sell | 21,156 | $8.20 | $173K | Direct | May 28, 2026 (2d) |
| Feb 23, 2026 | OCUL | ↓ Sell | 20,056 | $8.28 | $166K | Direct | Feb 25, 2026 (2d) |
| Feb 12, 2026 | OCUL | ↓ Sell | 124,882 | $9.04 | $1.1M | Direct | Feb 17, 2026 (5d) |
| Nov 24, 2025 | OCUL | ↓ Sell | 19,530 | $12.04 | $235K | Direct | Nov 26, 2025 (2d) |
| Aug 25, 2025 | OCUL | ↓ Sell | 21,494 | $12.04 | $259K | Direct | Aug 27, 2025 (2d) |
| May 23, 2025 | OCUL | ↓ Sell | 21,219 | $7.18 | $152K | Direct | May 27, 2025 (4d) |
| Feb 24, 2025 | OCUL | ↓ Sell | 21,475 | $6.87 | $148K | Direct | Feb 26, 2025 (2d) |
| Nov 25, 2024 | OCUL | ↓ Sell | 20,680 | $9.01 | $186K | Direct | Nov 27, 2024 (2d) |
| Aug 23, 2024 | OCUL | ↓ Sell | 20,880 | $9.02 | $188K | Direct | Aug 27, 2024 (4d) |
| May 23, 2024 | OCUL | ↓ Sell | 21,626 | $5.79 | $125K | Direct | May 28, 2024 (5d) |
| Apr 5, 2021 | ISEE | ↓ Sell | 28,301 | $6.34 | $179K | Direct | Apr 5, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OCUL insiders
Open-market trades in the last 12 months
About Pravin Dugel's insider trades
Pravin Dugel is See Remarks at Ocular Therapeutix (OCUL). Since Apr 5, 2021, Pravin has reported no open-market purchases and 12 sales worth $3.2M on SEC Form 4. In the last 12 months: 5 sales ($1.9M).
Their filings also include grants and awards (14 filings), option exercises (10 filings), gifts (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OCUL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.